Serum Institute plans to cut monthly production of Covishield by 50%
Tuesday, December 7, 2021, 22:04
The company has ramped up Covid-19 vaccine production and taken its capacity to 250 million doses a month in December 2021. SII has a stockpile of 500 million doses with them, which has a shelf life of nine months.
Powered by WPeMatico
You can follow any responses to this entry through the
RSS 2.0 feed.
Both comments and pings are currently closed.
Comments are closed for this story.